Is Hemoglobin A1c the Right Outcome for Studies of Diabetes?

JAMA. 2017 Mar 14;317(10):1017-1018. doi: 10.1001/jama.2017.0029.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Biomarkers / blood
  • Blood Glucose
  • Cardiovascular Diseases / etiology
  • Cardiovascular Diseases / prevention & control
  • Clinical Trials as Topic
  • Diabetes Mellitus, Type 2 / blood*
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Diabetic Angiopathies / prevention & control
  • Diabetic Cardiomyopathies / prevention & control
  • Drug Approval
  • Glycated Hemoglobin A*
  • Humans
  • Hypoglycemic Agents / adverse effects
  • Hypoglycemic Agents / therapeutic use*
  • Practice Guidelines as Topic
  • United States
  • United States Food and Drug Administration

Substances

  • Biomarkers
  • Blood Glucose
  • Glycated Hemoglobin A
  • Hypoglycemic Agents